J D Tyler

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo.

J D Tyler, Stephen J. Galli, Mary Ellen Snider et al. · The Journal of Experimental Medicine · 1984 · 67 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the <i>H-2k</i> haplotype.

David Steinmuller, J D Tyler, C S David · The Journal of Immunology · 1981 · 33 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.

J D Tyler, David Steinmuller · The Journal of Immunology · 1981 · 17 citations · Full text

Life Sciences, Cell Biology, Immunology +14